Evidence Level C
Poor quality observational (cohort) studies or methodologically flawed randomized controlled trials (RCTs) of <200 participants.
Lung function: there is poor-quality evidence to support the use of intravenous magnesium in people with severe acute asthma. Further studies are needed.
More info from BMJ Clinical Evidence
